VNDA Vanda Pharmaceuticals Inc.
$3.75
Vanda Pharmaceuticals Inc. (VNDA) Earnings News
Earnings press releases, previews and reviews for Vanda Pharmaceuticals Inc. (VNDA), newest first. Our most recent is review: Vanda Pharmaceuticals Beats on a Timing-Aided Quarter, but a Guidance Cut to the Old Floor and Slower Launches Overshadow the Print.
Wednesday
October 28, 2026
6:37 PM ET
Vanda Pharmaceuticals Beats on a Timing-Aided Quarter, but a Guidance Cut to the Old Floor and Slower Launches Overshadow the Print
Earnings Whispers · Review
Wednesday
October 28, 2026
4:01 PM ET
Vanda Pharmaceuticals Reports Third Quarter 2026 Financial Results
Thursday
October 22, 2026
7:22 AM ET
Vanda Needs a Clean Third Quarter as Fanapt Gains Battle Hetlios Erosion and Cash Burn
Earnings Whispers · Preview
Wednesday
October 21, 2026
5:40 PM ET
Vanda Pharmaceuticals to Announce Third Quarter 2026 Financial Results on October 28, 2026
Wednesday
August 5, 2026
4:01 PM ET
Vanda Pharmaceuticals Reports Second Quarter 2026 Financial Results
Wednesday
July 29, 2026
4:31 PM ET
Vanda Pharmaceuticals to Announce Second Quarter 2026 Financial Results on August 5, 2026